$0.5689
At close: Jan 21, 5:02 PM EDT
$0.5735
0.004600.81%
After Hours: 5:02 PM EDT
Comments
Loading...
Lyell Immunopharma (LYEL) Forecast
NewsEarningsLyell Immunopharma (LYEL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLyell Immunopharma (NASDAQ:LYEL) Stock Quotes, Forecast and News Summary
Lyell Immunopharma Stock (NASDAQ: LYEL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lyell Immunopharma (LYEL) stock?
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Who are Lyell Immunopharma (LYEL) competitors?
Other companies in Lyell Immunopharma’s space includes: Macrogenics (NASDAQ:MGNX), Zentalis Pharma (NASDAQ:ZNTL), Monopar Therapeutics (NASDAQ:MNPR), Adaptimmune Therapeutics (NASDAQ:ADAP) and Genfit (NASDAQ:GNFT).
What is the forecast, or price target, for Lyell Immunopharma (LYEL) stock?
Lyell Immunopharma has a consensus price target of $2.75.
What is the current price for Lyell Immunopharma (LYEL)?
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $0.5735 last updated January 21, 2025 at 5:02 PM EST.
Does Lyell Immunopharma (LYEL) pay a dividend?
There are no upcoming dividends for Lyell Immunopharma.
When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?
Lyell Immunopharma’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Lyell Immunopharma (LYEL) going to split?
There is no upcoming split for Lyell Immunopharma.
What sector and industry does Lyell Immunopharma (LYEL) operate in?
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.